MedPath

Granulation Technology Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

Carisoprodol Tablets, USP, 350 mg

Approval Date
Mar 8, 2024
FDA

PredniSONE Tablets, USP, 5 mg

Approval Date
Mar 6, 2024
FDA

Methocarbamol Tablets, USP, 500 mg

Approval Date
Dec 28, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.